Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE10A | Q9Y233 | 2/20 | 0.39 |
| ▸ | AHR | P35869 | 4/20 | 0.34 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.32 |
| ▸ | HTR1A | P08908 | 1/20 | 0.31 |
| ▸ | DRD2 | P14416 | 1/20 | 0.31 |
| ▸ | DRD4 | P21917 | 1/20 | 0.31 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.31 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.31 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.31 |
| ▸ | DRD3 | P35462 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL798826 | 0.83 | DYRK1A (0.34) | AHRDYRK1A | |
| SCHEMBL2067022 | 0.80 | DYRK1A (0.50) | PDE10AAHRDYRK1AKDM4E | |
| SCHEMBL6620552 | 0.79 | KDM4E (0.42) | PDE10AAHRDYRK1AHTR1ADRD2 | |
| SCHEMBL12891186 | 0.78 | PDE10A (0.43) | PDE10AAHR | |
| SCHEMBL756100 | 0.77 | KDM4E (0.50) | PDE10AAHRDYRK1AHTR1ADRD2 | |
| SCHEMBL18806166 | 0.76 | AHR (0.33) | PDE10AAHRDYRK1AKDM4E | |
| SCHEMBL2065644 | 0.76 | DRD2 (0.32) | DYRK1AHTR1ADRD2DRD4ADRA1D | |
| SCHEMBL3086869 | 0.76 | KDM4E (0.44) | PDE10AAHRDYRK1AHTR1ADRD2 | |
| SCHEMBL2065281 | 0.75 | PDE10A (0.50) | PDE10AAHRHTR1ADRD2DRD4 | |
| SCHEMBL24362734 | 0.73 | MCHR1 (0.32) | HTR1ADRD2DRD4ADRA1DADRA1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8399381-B2 | Condensed heterocyclic sulfonyl urea compound, a herbicide containing the same, and a method for weed control using the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2013-03-19 | — | — | US | disclosed |
| US-8399381-B2 | Condensed heterocyclic sulfonyl urea compound, a herbicide containing the same, and a method for weed control using the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2013-03-19 | — | — | US | disclosed |
| US-7816526-B2 | Condensed heterocyclic sulfonyl urea compound, a herbicide containing the same, and a method for weed control using the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-10-19 | — | — | US | disclosed |
| US-7816526-B2 | Condensed heterocyclic sulfonyl urea compound, a herbicide containing the same, and a method for weed control using the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-10-19 | — | — | US | disclosed |
| US-20100160163-A1 | Fused heterocyclic sulfonylurea compound, herbicide containing the same, and method for controlling weed with the same | TANAKA YASUSHI | 2010-06-24 | — | — | US | disclosed |
| US-20100160163-A1 | Fused heterocyclic sulfonylurea compound, herbicide containing the same, and method for controlling weed with the same | TANAKA YASUSHI | 2010-06-24 | — | — | US | disclosed |
| EP-1466527-B1 | FUSED HETEROCYCLIC SULFONYLUREA COMPOUND, HERBICIDE CONTAINING THE SAME, AND METHOD OF CONTROLLING WEED WITH THE SAME | SUMITOMO CHEMICAL CO (JP) | 2008-07-16 | — | — | EP | disclosed |
| US-20050032650-A1 | Fused heterocyclic sulfonylurea compound herbicide containing the same and method of controlling weed with the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2005-02-10 | — | — | US | disclosed |
| EP-1466527-A1 | FUSED HETEROCYCLIC SULFONYLUREA COMPOUND, HERBICIDE CONTAINING THE SAME, AND METHOD OF CONTROLLING WEED WITH THE SAME | Sumitomo Chemical Takeda Agro Company, Limited (JP) | 2004-10-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100160163-A1 | Fused heterocyclic sulfonylurea compound, herbicide containing the same, and method for controlling weed with the same | NOTUM, WEE1, DDT | PDE10A 741/4885AHR 672/4885DYRK1A 580/4885 |
| US-20050032650-A1 | Fused heterocyclic sulfonylurea compound herbicide containing the same and method of controlling weed with the same | NOTUM, WEE1, DDT | PDE10A 632/4885AHR 820/4885DYRK1A 576/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.